Tech Company Financing Transactions

Dewpoint Therapeutics Funding Round

On 2/12/2022, Dewpoint Therapeutics raised $150 million in Series C funding from SoftBank Vision Fund, 3E Bioventures and Arch Venture Partners.

Transaction Overview

Announced On
2/12/2022
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series C
Proceeds Purpose
Proceeds from the financing will be used to advance multiple pipeline programs through to IND and further invest in Dewpoint's fully integrated, multi-component biology platform as well as its artificial intelligence-driven data science platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6 Tide St. 300
Boston, MA 02210
USA
Phone
Undisclosed
Email Address
Overview
Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest diseases.
Profile
Dewpoint Therapeutics LinkedIn Company Profile
Social Media
Dewpoint Therapeutics Company Twitter Account
Company News
Dewpoint Therapeutics News
Facebook
Dewpoint Therapeutics on Facebook
YouTube
Dewpoint Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amir Nashat
  Amir Nashat LinkedIn Profile  Amir Nashat Twitter Account  Amir Nashat News  Amir Nashat on Facebook
Chief Operating Officer
Bruce Beutel
  Bruce Beutel LinkedIn Profile  Bruce Beutel Twitter Account  Bruce Beutel News  Bruce Beutel on Facebook
Chief Scientific Officer
Mark Murcko
  Mark Murcko LinkedIn Profile  Mark Murcko Twitter Account  Mark Murcko News  Mark Murcko on Facebook
Founder
Anthony Hyman
  Anthony Hyman LinkedIn Profile  Anthony Hyman Twitter Account  Anthony Hyman News  Anthony Hyman on Facebook
Founder
Richard Young
  Richard Young LinkedIn Profile  Richard Young Twitter Account  Richard Young News  Richard Young on Facebook
Vice President
William Chen
  William Chen LinkedIn Profile  William Chen Twitter Account  William Chen News  William Chen on Facebook
Vice President
Peter Dandliker
  Peter Dandliker LinkedIn Profile  Peter Dandliker Twitter Account  Peter Dandliker News  Peter Dandliker on Facebook
Vice President
Stephen Hale
  Stephen Hale LinkedIn Profile  Stephen Hale Twitter Account  Stephen Hale News  Stephen Hale on Facebook
Vice President
Alexander Szewczak
  Alexander Szewczak LinkedIn Profile  Alexander Szewczak Twitter Account  Alexander Szewczak News  Alexander Szewczak on Facebook
Vice President
Rebecca Zacks
  Rebecca Zacks LinkedIn Profile  Rebecca Zacks Twitter Account  Rebecca Zacks News  Rebecca Zacks on Facebook
VP - Bus. Development
Scott Peterson
  Scott Peterson LinkedIn Profile  Scott Peterson Twitter Account  Scott Peterson News  Scott Peterson on Facebook
VP - Human Resources
Holly Abernethy
  Holly Abernethy LinkedIn Profile  Holly Abernethy Twitter Account  Holly Abernethy News  Holly Abernethy on Facebook
VP - R & D
Ann Kwong
  Ann Kwong LinkedIn Profile  Ann Kwong Twitter Account  Ann Kwong News  Ann Kwong on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/12/2022: RareCircles venture capital transaction
Next: 2/12/2022: Getlabs venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary